Raises $60 Million Series C And Receives FDA Clearance For Smartphone-Based Diagnostic Test

Today,, an Israel-based healthtech startup that turns smartphone cameras into urine-testing medical devices, has announced a $60 million Series C funding round. The company has also received FDA clearance from the U.S. Food and Drug Administration (FDA) for its smartphone-based test to be used in the aid of diagnosing chronic kidney disease (CKD), which affects over 35 million Americans.

Read the full article in Forbes.